Search

Martin Deibel

from Kalamazoo, MI
Get Report
Also known as:
Martin R Deibel
Phone and address:
1009 Par 4 Rd, Kalamazoo, MI 49008
(269) 382-3260
Related to:
Jeffrey R Deibel, 40Winifred D Gower, 99Brian W Deibel, 37Edith J Deibel, 98Megan D Deibel, 71William R Gower
Connected to:
Abby M Deibel, 38Jody R Deibel, 67Marianne P Deibel, 62Nancy J Deibel, 80Ryan J Deibel, 35Tinsley L Deibel, 76Camilla R Deiber, 57Gerald A Deiber, 91Candace M Deibert, 74Chris M Deibert, 66

Martin Deibel Phones & Addresses

  • 1009 Par 4 Rd, Kalamazoo, MI 49008 (269) 382-3260
  • 3139 Walden Ravines, Columbus, OH 43221 (614) 876-7019
  • 3139 Walden Ravines, Columbus, OH 43221 (614) 619-1451

Work

Position: Service Occupations

Education

Degree: High school graduate or higher

Emails

e***[email protected]

Resumes

Resumes

Martin Deibel Photo 1

Chief Scientific Officer

View page
Position:
CSO at Proteos
Location:
Kalamazoo, Michigan Area
Industry:
Biotechnology
Work:
Proteos since Oct 2010
CSO
Proteos Inc Sep 2003 - Oct 2010
Head, Protein Purification
Upjohn, Pharmacia & Upjohn, Pharmacia Nov 1984 - Sep 2003
Senior Research Scientist
University of Kentucky May 1977 - Nov 1984
Postdoctoral and Research Assistant Professor
Education:
The Ohio State University 1972 - 1977
Ph.D., Biochemistry
Martin Deibel Photo 2

Martin Deibel

View page

Publications

Us Patents

Soluble, Active Recombinant Human Mao-B

View page
US Patent:
20020164744, Nov 7, 2002
Filed:
Apr 12, 2002
Appl. No.:
10/121498
Inventors:
Martin Deibel - Kalamazoo MI, US
Ronald Klein - Schoolcraft MI, US
Anthony Yem - Kalamazoo MI, US
International Classification:
C12N009/06
C07H021/04
C12P021/02
C12N005/06
US Classification:
435/191000, 435/069100, 435/320100, 435/325000, 536/023200
Abstract:
Monoamine oxidase B is an integral polypeptide of the outer mitochondrial membrane. Purified, soluble, biologically active human MAO-B is obtained by recombinant methods in amounts useful for high volume screening.

Catalytic Macro Molecules Having Cdc25B Like Activity

View page
US Patent:
60748516, Jun 13, 2000
Filed:
May 1, 1997
Appl. No.:
8/848810
Inventors:
Martin R. Deibel - Kalamazoo MI
Anthony W. Yem - Kalamazoo MI
Cindy L. Wolfe - Portage MI
Assignee:
Pharmacia & UpJohn Company - Kalamazoo MI
International Classification:
C12P 2102
C12N 910
US Classification:
435 697
Abstract:
This invention discloses novel forms of catalytic macro molecules that are related to cdc25B, a cell cycle specific phosphatase. These special domains of cdc25B, special fusions with GST, and unique peptides and proteins, their utility, and the method of making them are all described.

Protein Affecting K.sub.atp Channels

View page
US Patent:
58564497, Jan 5, 1999
Filed:
Nov 17, 1994
Appl. No.:
8/341401
Inventors:
Vincent E. Groppi - Kalamazoo MI
Martin R. Deibel - Kalamazoo MI
Mark L. Wolfe - Portage MI
Anthony W. Yem - Kalamazoo MI
Assignee:
Pharmacia & Upjohn Company - Kalamazoo MI
International Classification:
C07K 100
C12P 2100
A61K 3800
US Classification:
530395
Abstract:
This invention describes the isolation and identification of a new protein, p56, useful for the identification of drugs that will selectively open or close K channels. The protein p56 has a molecular weight of about 56,000 daltons and the N-terminal peptide sequence is: Glu-Pro-Arg-Ala-Pro-Pro-Glu-Lys-Ile-Ala-Ile-Val-Gly-Ala-Gly-Ile.

Protein Affecting K.sub.atp Channels

View page
US Patent:
59257423, Jul 20, 1999
Filed:
Aug 26, 1997
Appl. No.:
8/920067
Inventors:
Vincent E. Groppi - Kalamazoo MI
Martin R. Deibel - Kalamazoo MI
Mark L. Wolfe - Portage MI
Anthony W. Yem - Kalamazoo MI
Assignee:
Pharmacia & Upjohn Company - Kalamazoo MI
International Classification:
C07K 1400
US Classification:
530395
Abstract:
This invention describes the isolation and identification of a new protein, p56, useful for the identification of drugs that will selectively open or close K channels. The protein p56 has a molecular weight of about 56,000 daltons and the N-terminal peptide sequence is: Glu-Pro-Arg-Ala-Pro-Pro-Glu-Lys-Ile-Ala-Ile-Val-Gly-Ala-Gly-Ile.

Recombinant S. Aureus Peptide Deformylase

View page
US Patent:
20020102250, Aug 1, 2002
Filed:
Jun 29, 2001
Appl. No.:
09/895951
Inventors:
Martin Deibel - Kalamazoo MI, US
Anthony Yem - Kalamazoo MI, US
Cindy Wolfe - Portage MI, US
Anne Vosters - Kalamazoo MI, US
International Classification:
A61K038/46
C12N009/52
US Classification:
424/094600, 435/220000
Abstract:
An peptide deformylase iron complex composition, a method of isolating the composition, and a method of using the composition to screen for compounds that interact with a peptide deformylase are provided. The composition of the invention retains greater than about 95% of its catalytic deformylase activity after being stored at a protein concentration of greater than about 10 mg/ml in 50% glycerol at -20 C. for six months.
Control profile
Martin Deibel from Kalamazoo, MI Get Report